Dose constraints for hypofractionated, dose escalated radiotherapy in malignant pleural mesothelioma

被引：0
|
作者：
Ashton, M. [1 ]
O'Rourke, N. [1 ]
Harrow, S. [1 ]
Currie, S. [2 ]
Kearns, D. [2 ]
Valentine, R. [2 ]
机构：
[1] Beatson West Scotland Canc Ctr, Clin Oncol, Glasgow, Lanark, Scotland
[2] Beatson West Scotland Canc Ctr, Radiotherapy Planning, Glasgow, Lanark, Scotland
来源：
RADIOTHERAPY AND ONCOLOGY | 2018年 / 127卷
关键词：
D O I：
10.1016/S0167-8140(18)30930-7
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
OC-0620
引用
收藏
页码：S328 / S328
页数：1
相关论文
共 50 条
  • [1] SYSTEMS-2: Generation of dose constraints for a hypofractionated, dose escalated radiotherapy regimen for malignant pleural mesothelioma
    Ashton, M.
    Chalmers, A.
    O'Rourke, N.
    Harrow, S.
    Smith, S.
    Valentine, R.
    Kearns, D.
    [J]. LUNG CANCER, 2017, 103 : S27 - S28
  • [2] HIGH DOSE RADIOTHERAPY IN 14 CASES OF MALIGNANT PLEURAL MESOTHELIOMA
    ESCHWEGE, F
    SCHLIENGER, M
    [J]. JOURNAL DE RADIOLOGIE D ELECTROLOGIE ET DE MEDECINE NUCLEAIRE, 1973, 54 (03): : 255 - 259
  • [3] High-dose palliative radiotherapy for malignant pleural mesothelioma
    Foroudi, Farshad
    Smith, Jennifer G.
    Putt, Faye
    Wada, Morikatsu
    [J]. JOURNAL OF MEDICAL IMAGING AND RADIATION ONCOLOGY, 2017, 61 (06) : 797 - 803
  • [4] SYSTEMS-2: Randomized Phase II Trial of Standard Versus Dose Escalated Radiotherapy for Pain in Malignant Pleural Mesothelioma
    Ashton, M.
    O'Rourke, N.
    Macleod, N.
    Smith, S.
    Valentine, R.
    Laird, B.
    Sheridan, S.
    Alexander, L.
    Chalmers, A.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S2287 - S2287
  • [5] Improved Outcomes With Dose Escalated Hypofractionated Radiotherapy for Prostate Cancer
    Mackenzie, J.
    Law, A. B.
    Kerr, G. R.
    Higgins, G. S.
    Howard, G. C. W.
    Malik, J. M.
    McLaren, D. B.
    [J]. EUROPEAN JOURNAL OF CANCER, 2011, 47 : S495 - S495
  • [6] SYSTEMS-2: a randomised phase II trial of standard versus dose escalated radiotherapy in the treatment of pain in malignant pleural mesothelioma
    Ashton, M.
    O'Rourke, N.
    Macleod, N.
    Chalmers, A.
    [J]. LUNG CANCER, 2016, 91 : S71 - S71
  • [7] Urethral sparing increases the therapeutic ratio in dose escalated hypofractionated radiotherapy
    Spohn, S.
    Sachpazidis, I.
    Wiehle, R.
    Thomann, B.
    Sigle, A.
    Bronsert, P.
    Ruf, J.
    Benndorf, M.
    Nicolay, N.
    Sprave, T.
    Grosu, A.
    Baltas, D.
    Zamboglou, C.
    [J]. RADIOTHERAPY AND ONCOLOGY, 2021, 161 : S1106 - S1107
  • [8] The in-silico feasibility of dose escalated, hypofractionated radiotherapy for rectal cancer
    Devlin, Lynsey
    Grocutt, Laura
    Hunter, Bianca
    Chemu, Hiwot
    Duffton, Aileen
    McDonald, Alec
    Macleod, Nicholas
    McLoone, Philip
    O'Cathail, Sean M.
    [J]. CLINICAL AND TRANSLATIONAL RADIATION ONCOLOGY, 2022, 36 : 24 - 30
  • [9] Prevention of malignant seeding at drain sites by hypofractionated radiotherapy in patients with pleural mesothelioma
    Kara, Pinar
    Ugur, Isil
    Misirlioglu, Cem
    Kucukplakci, Bulent
    Ozgen, Aytul
    Elgin, Yesim
    Demirkasimoglu, Taciser
    Sanri, Ergun
    [J]. ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2010, 6 (03) : 187 - 190
  • [10] Defining PTV margins for dose escalated, hypofractionated radiotherapy for rectal cancer.
    Devlin, L.
    O'Cathail, S.
    Marshall, G.
    Hanna, C.
    Paterson, A.
    Duffton, A.
    [J]. RADIOTHERAPY AND ONCOLOGY, 2023, 182 : S249 - S249
12345